I suspect we can potentially start selling the 3D patch in Feb 2018 to India as well along with the US commercial launch providing they have skilled surgeons that can use it.
Ann: Regulatory approval to launch CardioCel in India, page-44
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.23 | $13.30 | $483.9K | 34.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $13.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |